Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations: 2009-2018

Historic Liabilities from Discontinued Operations for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Dec 2018 value amounting to $15.7 million.

  • Ironwood Pharmaceuticals' Liabilities from Discontinued Operations was N/A to $15.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $15.7 million for FY2018, which is N/A change from last year.
  • Ironwood Pharmaceuticals' Liabilities from Discontinued Operations amounted to $15.7 million in FY2018, which was up 1,053.89% from $1.4 million recorded in FY2009.
  • Over the past 5 years, Ironwood Pharmaceuticals' Liabilities from Discontinued Operations peaked at $15.7 million during FY2018, and registered a low of $15.7 million during FY2018.
  • In the last 1 years, Ironwood Pharmaceuticals' Liabilities from Discontinued Operations had a median value of $15.7 million in 2018 and averaged $15.7 million.